(Australia Stock Exchange, November 25, 2016, )

Al Bentley,
(Australia Stock Market, November 25, 2016 Sydney; November 24, 2016 New York, )
Al: Alabama
Bentley: British car, and, CIA Mormon Danite Dr. Robert Bentley, Governor, Alabama
(Genius Mormon Danites devised a scandal to get rid of Dr. Bentley before anybody realizes, he is a Mormon Danite. cc all Mormon attorneys

An Original Play by Nicole Nero Gaines
November 27

(Flyer on the sidewalk near Parlor hair salon, Atlantic Avenue between Third Avenue and Fourth Avenue, across the street from Times Plaza Post Office, Brooklyn, November 24, 2016)
Empowering our Community Through Health Education
If you complete the 4 sessions you will receive a $40 Target Card, and Gift Bag and a Certificate!
We offer food in every session!
(Flyer, YWCA Brooklyn, October 2013.  The “sista” in the lower right corner looks very much like my now deceased daughter Lisa before she was stricken with MS and died; she died a true and faithful servant of Jehovah.  cc all Mormon  attorneys)
(Mormon church of Satan “Sistas in Zion”, )
Peter Switzer
(Australia Stock Market, November 25, 2016 Sydney; November 24,2016 New Yorksisley-glow
Ford black pick up truck Indiana license plate number G741718, parked next door to Parlor hair salon, Atlantic Avenue, Brooklyn, November 2016.  (It is not yet well known, the fact that the vice president elect, Michael Pence, is a Mormon Danite pretending otherwise.)

(Market Watch, Futures, November 24,2016, 11:15pm, )

Suzanne A. “Sue” Sisley is a psychiatrist and former clinical assistant professor at the University of Arizona College of Medicine. She is known for her research into potential medical uses of marijuana.

Marijuana research and termination

In March 2014, Sisley’s study of marijuana use to treat post-traumatic stress disorder (PTSD) was approved by the National Institute on Drug Abuse.[1] After working at the University of Arizona for nearly eight years in various capacities, she was fired from the university in June 2014, ostensibly because of “funding and reorganization issues”; Sisley, however, maintained that it was because of her interest in studying the potential medical uses of marijuana to treat PTSD.[2][3] Sisley has also claimed that her university failed to provide a location for the trial to take place, and that the University of Arizona was “fearful of the word ‘marijuana’ and [did] not want… their brand aligned with this research.”[3] After she was terminated, her university released a statement saying that they had “not received political pressure to terminate any employee as has been suggested in some media and other reports.”[3] Sisley has also acknowledged that she is “not sold” on the efficacy of marijuana for this purpose, but that she does think it has shown enough promise to be studied in a controlled environment. Since being fired, Sisley’s research has been supported by the Multidisciplinary Association for Psychedelic Studies, a California-based nonprofit organization, which intends to look for a new university where it can be conducted.[4] On July 28, the University of Arizona denied Sisley’s appeal for reinstatement.[5]


The Multidisciplinary Association for Psychedelic Studies (MAPS) is a membership-based 501(c)(3) organization working to raise awareness and understanding of psychedelic substances. MAPS was founded in 1986 by Rick Doblin, and is now based in Santa Cruz, California.

MAPS helps scientists design, fund, and obtain regulatory approval for studies of the safety and effectiveness of a number of controlled substances. MAPS works closely with government regulatory authorities worldwide such as the United States Food and Drug Administration (FDA) and the European Medicines Agency(EMEA) to ensure that all of its sponsored research protocols conform to ethical and procedural guidelines for clinical drug research. Included in MAPS’ research efforts are MDMA (methylenedioxymethamphetamine) for the treatment of posttraumatic stress disorder (PTSD); LSD and psilocybin for the treatment of anxietycluster headaches, and depression associated with end-of-life issues; ibogaine for the treatment of opiate addictionayahuasca for the treatment of drug addiction and PTSD; medical marijuana for PTSD; and alternative delivery systems for medical marijuana such as vaporizers and water pipes. MAPS officials say the organization’s ultimate goal is to establish a network of clinics where these and other treatments can be provided together with other therapies under the guidance of trained, licensed physicians and therapists.[1]

In addition to sponsoring scientific research, MAPS organizes continuing medical education (CME) conferences, sponsors and presents lectures and seminars on the state of psychedelic and medical marijuana research, provides psychedelic harm reduction services through the Zendo Project at events such as music festivals and Burning Man, and publishes a triannual magazine-style publication, the MAPS Bulletin, with updates about its ongoing research efforts, legal struggles, and educational initiatives. MAPS also publishes books dealing with the science, history, and culture of psychedelic research and psychedelic therapy.[2]

 Psychedelic therapy refers to therapeutic practices involving the use of psychedelic drugs, particularly serotonergic psychedelics such as LSDpsilocybinDMTMDMAmescaline, and 2C-B, primarily to assist psychotherapy. As an alternative to synonyms such as “hallucinogen“, “entheogen“, “psychotomimetic” and other functionally constructed names, the use of the term psychedelic (“mind-manifesting”) emphasizes that those who use these drugs as part of a therapeutic practice believe these drugs can facilitate beneficial exploration of the psyche. In contrast to conventional psychiatric medication which is taken by the patient regularly or as-needed, in psychedelic therapy, patients remain in an extended psychotherapy session during the acute activity of the drug and spend the night at the facility. In the sessions with the drug, therapists are nondirective and support the patient in exploring their inner experience. Patients participate in psychotherapy before the drug psychotherapy sessions to prepare them and after the drug psychotherapy to help them integrate their experiences with the drug.[1]

(Mormon church of Satan “Sistas in Zion”, )